Gyre Therapeutics, Inc. (GYRE) Stock Price History
Historical prices from 2011 to 2026
Loading 10-year price history...
GYRE Historical Performance
Short-Term Returns
GYRE Stock Price Trajectory (2011–2026)
As of May 7, 2026, Gyre Therapeutics, Inc. (GYRE) trades at $8.04, representing a -7.7% return over the past year. The stock has delivered a -51.3% total return over five years (-34.7% CAGR), reflecting challenging market conditions.
The stock reached its all-time high of $47,990.25 on March 1, 2011. From this peak, GYRE has corrected -100.0%, currently trading 5% above its 200-day moving average, indicating continued institutional support.
When compared to Healthcare sector peers HALO (+11.7% 1Y), ARDX (+79.7% 1Y), and PRAX (+860.9% 1Y), GYRE has underperformed the peer group average. Compare GYRE vs HALO →
GYRE Historical Price Data (2011–2026)
Showing 30 of 3,650 records| Date | Open | High | Low | Close | Volume | Change % |
|---|---|---|---|---|---|---|
| 2026-05-06 | 7.88 | 8.09 | 7.73 | 8.04 | 128K | +3.34% |
| 2026-05-05 | 8.00 | 8.00 | 7.68 | 7.78 | 61K | -1.77% |
| 2026-05-04 | 7.78 | 8.05 | 7.73 | 7.92 | 73K | +1.54% |
| 2026-05-01 | 7.68 | 7.89 | 7.45 | 7.80 | 71K | +1.56% |
| 2026-04-30 | 7.41 | 7.70 | 7.41 | 7.68 | 44K | +4.49% |
| 2026-04-29 | 7.70 | 7.70 | 7.30 | 7.35 | 44K | -4.17% |
| 2026-04-28 | 7.70 | 7.76 | 7.63 | 7.67 | 44K | +0.52% |
| 2026-04-27 | 7.58 | 7.65 | 7.47 | 7.63 | 32K | +2.55% |
| 2026-04-24 | 7.35 | 7.65 | 7.34 | 7.44 | 32K | 0.00% |
| 2026-04-23 | 7.73 | 7.80 | 7.41 | 7.44 | 45K | -3.75% |
| 2026-04-22 | 7.92 | 7.92 | 7.72 | 7.73 | 34K | -1.78% |
| 2026-04-21 | 8.00 | 8.09 | 7.86 | 7.87 | 68K | -0.88% |
| 2026-04-20 | 8.02 | 8.03 | 7.86 | 7.94 | 50K | -1.98% |
| 2026-04-17 | 7.97 | 8.19 | 7.97 | 8.10 | 90K | +2.53% |
| 2026-04-16 | 8.00 | 8.00 | 7.81 | 7.90 | 35K | -1.50% |
| 2026-04-15 | 7.88 | 8.06 | 7.85 | 8.02 | 62K | +2.30% |
| 2026-04-14 | 7.89 | 7.92 | 7.78 | 7.84 | 36K | +1.95% |
| 2026-04-13 | 7.37 | 7.71 | 7.31 | 7.69 | 50K | +4.06% |
| 2026-04-10 | 7.18 | 7.41 | 7.18 | 7.39 | 43K | +2.07% |
| 2026-04-09 | 7.06 | 7.25 | 7.03 | 7.24 | 34K | +2.12% |
| 2026-04-08 | 7.26 | 7.43 | 7.04 | 7.09 | 93K | -0.42% |
| 2026-04-07 | 7.08 | 7.15 | 6.95 | 7.12 | 77K | 0.00% |
| 2026-04-06 | 7.19 | 7.24 | 7.11 | 7.12 | 76K | 0.00% |
| 2026-04-02 | 7.00 | 7.18 | 6.91 | 7.12 | 61K | -1.52% |
| 2026-04-01 | 7.06 | 7.27 | 7.06 | 7.23 | 68K | +3.73% |
| 2026-03-31 | 6.95 | 7.08 | 6.90 | 6.97 | 100K | +1.90% |
| 2026-03-30 | 6.83 | 6.91 | 6.77 | 6.84 | 103K | +0.88% |
| 2026-03-27 | 6.88 | 6.99 | 6.78 | 6.78 | 158K | -3.69% |
| 2026-03-26 | 7.01 | 7.28 | 7.01 | 7.04 | 90K | -1.95% |
| 2026-03-25 | 7.11 | 7.34 | 7.10 | 7.18 | 101K | +3.46% |
See GYRE's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs GYRE Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare GYRE vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonGYRE — Frequently Asked Questions
Quick answers to the most common questions about buying GYRE stock.
How has GYRE stock performed recently?
GYRE declined -7.7% over the past year, below its 5-year annualized CAGR of -34.7%. The stock trades above its 200-day moving average, reflecting the downtrend.
What is GYRE's all-time high price?
Gyre Therapeutics, Inc. reached $47990.25 on 2011-03-01. The 52-week high is $11.78. Current 1-year return of -7.7% places the stock further from historical peaks.
Where can I download GYRE historical price data?
This page provides GYRE daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2011-2026, downloadable in CSV format.